These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 7848483)

  • 21. [Prevention of occlusion following peripheral bypass surgery using oral anticoagulants or acetylsalicylic acid: a randomized comparison within the Dutch BOA study].
    Tangelder MJ; Eikelboom BC; Lawson JA; Algra A
    Ned Tijdschr Geneeskd; 1995 Jul; 139(29):1504-6. PubMed ID: 7630459
    [No Abstract]   [Full Text] [Related]  

  • 22. Aspirin and dipyridamole in the prevention of coronary disease and coronary artery bypass graft occlusion.
    Chong BH
    Aust N Z J Med; 1992 Dec; 22(6):645-6. PubMed ID: 1489286
    [No Abstract]   [Full Text] [Related]  

  • 23. Does 111indium-platelet deposition predict patency in prosthetic arterial grafts?
    Goldman M; Hall C; Dykes J; Hawker RJ; McCollum CN
    Br J Surg; 1983 Oct; 70(10):635-8. PubMed ID: 6414571
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Optimal antithrombotic therapy following aortocoronary bypass: a meta-analysis.
    Fremes SE; Levinton C; Naylor CD; Chen E; Christakis GT; Goldman BS
    Eur J Cardiothorac Surg; 1993; 7(4):169-80. PubMed ID: 8481254
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Heparin-bonded expanded polytetrafluoroethylene femoropopliteal bypass grafts outperform expanded polytetrafluoroethylene grafts without heparin in a long-term comparison.
    Samson RH; Morales R; Showalter DP; Lepore MR; Nair DG
    J Vasc Surg; 2016 Sep; 64(3):638-47. PubMed ID: 27139782
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Failure of combined acetylsalicylic acid and dipyridamole to prevent occlusion of aortocoronary venous bypass graft.
    Thaulow E; Frøysaker T; Dale J; Vatne K
    Scand J Thorac Cardiovasc Surg; 1987; 21(3):215-20. PubMed ID: 3501902
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clopidogrel and aspirin versus clopidogrel alone on graft patency after coronary artery bypass grafting.
    Gao C; Ren C; Li D; Li L
    Ann Thorac Surg; 2009 Jul; 88(1):59-62. PubMed ID: 19559191
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Formation of a genuine aneurysm of the vein graft 16 years after femoropopliteal bypass grafting.
    Lemenev VL; Mikhaĭlov IP; Kungurtsev EV; Shcherbiuk AA
    Angiol Sosud Khir; 2004; 10(3):65-8. PubMed ID: 15622395
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Randomised placebo controlled trial of aspirin and dipyridamole in the prevention of coronary vein graft occlusion.
    Brooks N; Wright J; Sturridge M; Pepper J; Magee P; Walesby R; Layton C; Honey M; Balcon R
    Br Heart J; 1985 Feb; 53(2):201-7. PubMed ID: 3881108
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prevention of graft occlusion by aspirin, dipyridamole, and oral anticoagulants.
    Loeliger EA
    Lancet; 1993 Sep; 342(8874):806; author reply 807. PubMed ID: 8103893
    [No Abstract]   [Full Text] [Related]  

  • 31. P values may lack power: the choice of conduit for above-knee femoropopliteal bypass graft.
    Mills JL
    J Vasc Surg; 2000 Aug; 32(2):402-5. PubMed ID: 10918003
    [No Abstract]   [Full Text] [Related]  

  • 32. Prevention of graft occlusion by aspirin, dipyridamole, and oral anticoagulants.
    Houben JJ; Nicolai G
    Lancet; 1993 Sep; 342(8874):806-7. PubMed ID: 8103894
    [No Abstract]   [Full Text] [Related]  

  • 33. Internal mammary artery and saphenous vein graft patency. Effects of aspirin.
    Goldman S; Copeland J; Moritz T; Henderson W; Zadina K; Ovitt T; Kern KB; Sethi G; Sharma GV; Khuri S
    Circulation; 1990 Nov; 82(5 Suppl):IV237-42. PubMed ID: 2225410
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A meta-analysis to compare Dacron versus polytetrafluroethylene grafts for above-knee femoropopliteal artery bypass.
    Rychlik IJ; Davey P; Murphy J; O'Donnell ME
    J Vasc Surg; 2014 Aug; 60(2):506-15. PubMed ID: 24973288
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prosthetic above-knee femoropopliteal bypass grafting: five-year results of a randomized trial.
    Green RM; Abbott WM; Matsumoto T; Wheeler JR; Miller N; Veith FJ; Money S; Garrett HE
    J Vasc Surg; 2000 Mar; 31(3):417-25. PubMed ID: 10709052
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Five-year outcomes following a randomized trial of femorofemoral and femoropopliteal bypass grafting with heparin-bonded or standard polytetrafluoroethylene grafts.
    Lindholt JS; Houlind K; Gottschalksen B; Pedersen CN; Ravn H; Viddal B; Pedersen G; Rasmussen M; Wedel C; Bramsen MB
    Br J Surg; 2016 Sep; 103(10):1300-5. PubMed ID: 27477951
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Factors determining late patency of aortobifemoral bypass graft].
    Davidović LB; Lotina SI; Kostić DM; Cinara II; Cvetković SD; Stojanov PL; Velimirović DB; Marković MM; Pejkić SA; Vukotić AM
    Srp Arh Celok Lek; 1997; 125(1-2):24-35. PubMed ID: 17974352
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The prostacyclin analogue beraprost sodium prevents occlusion of bypass grafts in patients with lower extremity arterial occlusive disease: a 20-year retrospective study.
    Murakami M; Watanabe M; Furukawa H; Nakahara H
    Ann Vasc Surg; 2005 Nov; 19(6):838-42. PubMed ID: 16247707
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Antiplatelet therapy to prevent coronary artery bypass graft occlusion.
    Buring JE; Hennekens CH
    Circulation; 1990 Sep; 82(3):1046-8. PubMed ID: 2393990
    [No Abstract]   [Full Text] [Related]  

  • 40. [Naftidrofuryl in patients with prosthetic femoral-popliteal bypass].
    Noppeney T; Kasprzak P; Raithel D; Hirche H
    Vasa Suppl; 1988; 24():60-6. PubMed ID: 3062825
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.